IRIS
BAROCELLI, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.311
AS - Asia 14.258
EU - Europa 11.474
SA - Sud America 1.956
AF - Africa 779
Continente sconosciuto - Info sul continente non disponibili 373
OC - Oceania 13
Totale 52.164
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.725
SG - Singapore 4.883
CN - Cina 4.213
VN - Vietnam 2.228
FI - Finlandia 1.997
SE - Svezia 1.808
IE - Irlanda 1.645
IT - Italia 1.620
BR - Brasile 1.499
DE - Germania 1.253
UA - Ucraina 979
HK - Hong Kong 957
FR - Francia 503
ZA - Sudafrica 490
TR - Turchia 484
GB - Regno Unito 435
BD - Bangladesh 411
NL - Olanda 395
CA - Canada 345
IN - India 284
RU - Federazione Russa 196
AR - Argentina 162
BE - Belgio 128
CI - Costa d'Avorio 119
MX - Messico 113
AT - Austria 96
ES - Italia 93
JP - Giappone 92
IQ - Iraq 89
ID - Indonesia 85
PH - Filippine 79
EC - Ecuador 75
PL - Polonia 65
PK - Pakistan 64
CO - Colombia 62
CZ - Repubblica Ceca 62
KR - Corea 61
RO - Romania 60
TH - Thailandia 57
VE - Venezuela 46
PY - Paraguay 34
MA - Marocco 33
EU - Europa 32
TW - Taiwan 31
LT - Lituania 29
CL - Cile 26
CM - Camerun 26
MY - Malesia 26
UZ - Uzbekistan 25
SA - Arabia Saudita 23
CR - Costa Rica 22
EG - Egitto 22
AZ - Azerbaigian 21
JM - Giamaica 21
KE - Kenya 21
JO - Giordania 20
PA - Panama 20
PE - Perù 18
TN - Tunisia 16
AE - Emirati Arabi Uniti 15
UY - Uruguay 15
BO - Bolivia 14
HN - Honduras 14
BG - Bulgaria 13
ET - Etiopia 13
AL - Albania 12
NP - Nepal 12
AU - Australia 11
DO - Repubblica Dominicana 11
HU - Ungheria 11
IR - Iran 11
KZ - Kazakistan 10
LB - Libano 10
OM - Oman 10
CH - Svizzera 9
DZ - Algeria 9
IL - Israele 9
TT - Trinidad e Tobago 9
NI - Nicaragua 8
GE - Georgia 7
HR - Croazia 7
PT - Portogallo 7
SI - Slovenia 7
SN - Senegal 7
BB - Barbados 6
RS - Serbia 6
SC - Seychelles 6
SV - El Salvador 6
SY - Repubblica araba siriana 6
BH - Bahrain 5
BY - Bielorussia 5
DK - Danimarca 5
EE - Estonia 5
MD - Moldavia 5
PS - Palestinian Territory 5
QA - Qatar 5
GA - Gabon 4
KG - Kirghizistan 4
LU - Lussemburgo 4
AO - Angola 3
Totale 51.765
Salva come PNG Salva come JPEG
Città #
Dallas 5.852
Singapore 2.602
Ashburn 1.843
Chandler 1.660
San Jose 1.646
Dublin 1.644
Santa Clara 1.294
Jacksonville 1.117
Beijing 1.012
Hong Kong 895
Ann Arbor 894
Dearborn 768
Ho Chi Minh City 685
Council Bluffs 553
Boardman 552
Parma 482
Hanoi 473
Johannesburg 467
Nanjing 428
New York 422
Izmir 399
Los Angeles 360
Shanghai 312
Princeton 310
Munich 294
Lauterbourg 287
Wilmington 213
San Mateo 210
Toronto 192
Hefei 189
Helsinki 178
Buffalo 152
Bremen 151
São Paulo 145
Hebei 133
Kunming 133
Nanchang 132
Shenyang 126
Brussels 124
Jinan 121
Abidjan 119
Moscow 107
Des Moines 99
Haiphong 97
Guangzhou 94
Columbus 92
Frankfurt am Main 92
Grafing 84
Chicago 83
Vienna 83
Woodbridge 83
Milan 81
Tianjin 80
Da Nang 79
Tokyo 78
Turku 74
Seattle 71
Changsha 64
Jiaxing 63
London 63
Montreal 59
Phoenix 59
Rio de Janeiro 56
Houston 55
Bologna 54
Brooklyn 53
Fremont 53
Warsaw 48
Denver 42
Hangzhou 42
Orem 42
The Dalles 41
Atlanta 40
Chennai 40
Norwalk 40
Jakarta 38
Zhengzhou 38
Amsterdam 37
Rome 37
Ottawa 34
Auburn Hills 33
Modena 33
Belo Horizonte 32
Biên Hòa 31
Manchester 31
Mexico City 31
Nuremberg 31
Poplar 31
Pune 31
Stockholm 31
Brno 30
Marseille 30
Boston 29
Hải Dương 29
Naples 29
Baghdad 28
Bangalore 27
Can Tho 27
Curitiba 27
Redondo Beach 27
Totale 32.642
Salva come PNG Salva come JPEG
Nome #
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 1.722
1,5-Benzodiazepines Part XIII. Substututed 4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amines and 4H-imidazo-[1,2-a][ 1,5]benzodiazepin-5-amines as analgesic, anti-inflammatory and/or antipyretic agents with low acute toxicity 1.697
1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists 1.653
1,5-Benzodiazepin tricyclic derivatives as analgersic, anti-inflammatory and /or antipyretic agents with very low acute gastrolesivity and toxicity 1.630
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line 266
1,8-Naphthyridines V. Novel N-substituted 5-amino-N,N-diethyl-9-isopropyl [1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamides, as potent anti-inflammatory and/or analgesic agents completely devoid of acute gastrolesivity 262
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach 261
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 257
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model 253
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 253
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 247
Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model 243
2-Aminobenzimidazoles as new potent H3-antagonists 233
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 231
Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm. (Lauraceae) calices from Amazonian Ecuador 228
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity. 227
3D-printed chitosan-based scaffolds: An in vitro study of human skin cell growth and an in-vivo wound healing evaluation in experimental diabetes in rats 225
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 224
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor. 224
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 221
Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation 216
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 214
Bifidobacterium bifidum PRL2010 alleviates intestinal ischemia/reperfusioni injury 211
Antinociceptive and gastroprotective effects of inhaled and orally administered Lavandula hybrida Reverchon “Grosso” essential oil 210
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 209
Discovery and development of Eph-ephrin antagonists endowed with antiangiogenic properties 209
Analgesic properties of benzisothiazole/ benzimidazole derivatives with acidic groups 205
Protective Effects of a Protease Inhibitor (Gabexate Mesilate) on Intestinal Ischemia/Reperfusion Injury in Rats 203
1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity. 202
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 202
Comparison of the effects of structurally different H2-antagonists on acid and pepsin activity stimulated by dimaprit in conscious cats 201
Aminobenzimidazoles as new potent H3-antagonists 201
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 200
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 200
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations. 200
Azionifarmacologiche di composti alchilaminoalchilfenilbenzisotiazolici sul trattogastrointestinale 199
Human colonoid-derived monolayers and Caco-2: comparative analysis of inflammatory responses 198
2,4-Substituted benzopyrano[4,3-d]pyrimidines and benzopyrano[4,3-d]pyrimidin-5-ones: synthesis and antiplatelet activity 198
1,8-Naphthyridines VII. New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and/or analgesic activities, but no acute gastrolesivity. 198
Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 system. 192
2-Amino-1,2-benzisothiazolin-3-one derivatives as powerful antiplatelet agents 192
[Experimental tracheal transplantation. Literature review and proposal of an original surgical technique]. 191
Design and structure-activity relationship of amino acid derivatives of lithocholic acid as novel EphA2 antagonists 191
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury 190
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 189
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 188
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 187
NEW EPH ANTAGONISTS DISCRIMINATING BETWEEN EPH-AS AND EPH-BS CLASSES 185
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 185
Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma 185
Caratterizzazione farmacologica in vitro di nuovi agonisti muscarinici analoghi dell'Oxotremorina 184
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 183
Discovery and development of small molecules targeting Eph-ephrin system in glioblastoma: an academic history 183
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 182
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 182
Structure–Activity Relationships and Mechanism of Action of Eph–ephrin Antagonists: Interaction of Cholanic Acid with the EphA2 Receptor 182
4-(1,2-benzisothiazol-3-)alkanoic and phenylalkanoic acids: synthesis and anti-inflammatory, analgesic and antipyretic activities 181
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 181
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation 180
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 180
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 179
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 178
4-(3-Oxo-1,2-benzisothiazolin-2-yl)alkanoic, phenyl and phenoxyalkanoic acids: synthesis and anti-inflammatory, analgesic, and antipyretic properties 178
Hake fish bone as a calcium source for efficient bone mineralization 178
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 177
270 Discovery, development and optimization of low molecular weight EPH–ephrin protein–protein inhibitors 177
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 177
Adaptive changes in rat ileum motility induced by mild mesenteric ischemia/reperfusion injury: role of endogenous mediators and reperfusion time 175
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 174
Distinct Roles of α4β2 and α7 Nicotinic Receptors in the Modulation of Inflammatory Responses in TNBS-Induced Colitis 174
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 173
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 172
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 171
The anti-H1-histaminic and antimuscarinic effect of 2- and 4-[benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds]. 171
2-Amino-1,2-benzisothiazolin-3-one Derivatives: Synthesis and Assessment of their Antiplatelet/Spasmolytic Effects 171
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling 171
A New Potent and Selective Histamine H3-Receptor Antagonist, 4(5)-{2-[4(5)-cyclohexylimidazol-2-ylthio]ethyl}imidazole 170
Analgesici-antipiretici benzopirano pirimidinici non acidici attivi per via orale privi di gastrolesività 170
Anomalous responses to histamine stimulation of guinea-pig oesophageal muscularis mucosae. 169
5-HT1A receptors as target to protect the intestine in an experimental model of colitis 169
A preliminary study of engineered nanoparticles effects on barrier function of airway epithelial monolayers 168
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 167
Biochemical platform for the identification of adverse effects triggered by free hemoglobin in guinea pigs 167
Perturbation of The EphA2-EphrinA1 System in Human Prostate Cancer Cells by Colonic (Poly)phenol Catabolites 167
Comparative screening of plant essential oils: phenylpropanoid moiety as basic core for antiplatelet activity 167
Analgesic activity of new hybrid muscarinic agonists in mice 166
Development of 3-oxo-cholenic derivatives as Eph antagonists able to block in vitro angiogenesis 166
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 165
Discovery of small-molecule targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases 164
Antinociceptive affects of inhalated and orally administered Lavandula hybrida Reverchon "Grosso" essential oil 164
Activation of proteinase-activated receptor 2 prevents gastrointestinal transit delay induced by ischemia/reperfusion in rats 164
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 164
5-Alkoxy-2-hydrazino and 5-methoxy-2-amino-5H[1]benzopyrano[4,3-d]pyrimidines: synthesis and pharmacological activity 163
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 163
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 163
Antiulcer long-term treatment in chronic ulcer rat 162
Inflammatory proteases released in a mouse model of intestinal ischemia 162
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 162
Motor responses of rat hypertrophic intestine following chronic obstruction 162
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 162
Totale 25.088
Salva come PNG Salva come JPEG
Categoria #
all - tutte 163.552
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.552
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.748 0 0 53 239 117 126 199 213 71 125 116 489
2022/20236.458 759 673 388 473 644 723 111 361 1.991 57 198 80
2023/20242.208 128 194 58 86 168 564 210 119 85 111 160 325
2024/20257.376 229 396 513 410 722 867 279 349 815 688 628 1.480
2025/202621.508 1.557 2.601 5.655 1.639 2.235 963 1.724 562 2.273 1.236 649 414
2026/20271.776 421 912 443 0 0 0 0 0 0 0 0 0
Totale 52.164